1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
Summary of imaging characteristics as univariate predictors of overall survival in 46 patients with gliomas
CharacteristicsNo.%HR (95% CI)P Value
Sequence
    2D31671
    3D15331.00 (0.44 to 2.29).99
Contrast enhancement
    None/less than that of choroid plexus15331
    Equal/more than that of choroid plexus31678.11 (2.44–26.90).0007
Ktrans (min−1)
    <0.051737.01
    ≥0.052963.07.63 (2.63–22.11).0002
Vp (mL/100 g)
    <52043.51.003
    ≥52656.54.17 (1.77–9.80).001